MicroRNA-145 is regulated by DNA methylation and p53 gene mutation in prostate cancer

Carcinogenesis

Volumn 32, Issue 5, 2011, Pages 772-778

  Suh, Seong O ^a,b   Chen, Yi ^a   Zaman, Mohd Saif ^a   Hirata, Hiroshi ^a   Yamamura, Soichiro ^a   Shahryari, Varahram ^a   Liu, Jan ^a   Tabatabai, Z Laura ^a   Kakar, Sanjay ^a   Deng, Guoren ^a   Tanaka, Yuichiro ^a   Dahiya, Rajvir ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b National Police Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; DNA; MICRORNA; PROTEIN P53;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA METHYLATION; GEL MOBILITY SHIFT ASSAY; GENE MUTATION; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; LASER CAPTURE MICRODISSECTION; MUTANT; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CANCER; RECEPTOR DOWN REGULATION; REGULATORY MECHANISM; RNA BINDING;

EID: 79955771439     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgr036     Document Type: Article

References (38)

1. Lagos-Quintana,M. et al. (2001) Identification of novel genes coding for small expressed RNAs. Science, 294, 853-858.
2. Michael,M.Z. et al. (2003) Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol. Cancer Res., 1, 882-891.
3. Lakshmipathy,U. et al. (2007) Micro RNA profiling: an easy and rapid method to screen and characterize stem cell populations. Methods Mol. Biol., 407, 97-114.
4. Cordes,K.R. et al. (2009) miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature, 460, 705-710.
5. Xu,N. et al. (2009) MicroRNA-145 regulates OCT4, SOX2, and KLF4 and represses pluripotency in human embryonic stem cells. Cell, 137, 647-658.
6. Iorio,M.V. et al. (2005) MicroRNA gene expression deregulation in human breast cancer. Cancer Res., 65, 7065-7070.
7. Liu,X. et al. (2009) Uncovering growth-suppressive microRNAs in lung cancer. Clin. Cancer Res., 15, 1177-1183.
8. Gramantieri,L. et al. (2009) MicroRNA-221 targets Bmf in hepatocellular carcinoma and correlates with tumor multifocality. Clin. Cancer Res., 15, 5073-5081.
9. Ichimi,T. et al. (2009) Identification of novel microRNA targets based on microRNA signatures in bladder cancer. Int. J. Cancer, 125, 345-352.
10. Amaral,F.C. et al. (2009) MicroRNAs differentially expressed in ACTHsecreting pituitary tumors. J. Clin. Endocrinol. Metab., 94, 320-323.
11. Akao,Y. et al. (2007) Downregulation of microRNAs-143 and -145 in Bcell malignancies. Cancer Sci., 98, 1914-1920.
12. Iorio,M.V. et al. (2007) MicroRNA signatures in human ovarian cancer. Cancer Res., 67, 8699-8707.
13. Porkka,K.P. et al. (2007) MicroRNA expression profiling in prostate cancer. Cancer Res., 67, 6130-6135.
14. Ozen,M. et al. (2008)Widespread deregulation of microRNA expression in human prostate cancer. Oncogene, 27, 1788-1793.
15. Schaefer,A. et al. (2010) Diagnostic and prognostic implications of micro-RNA profiling in prostate carcinoma. Int. J. Cancer, 126, 1166-1176.
16. Shi,B. et al. (2007) Micro RNA 145 targets the insulin receptor substrate-1 and inhibits the growth of colon cancer cells. J. Biol. Chem., 282, 32582-32590.
17. Sachdeva,M. et al. (2009) p53 represses c-Myc through induction of the tumor suppressor miR-145. Proc. Natl Acad. Sci. USA, 106, 3207-3212.
18. Sachdeva,M. et al. (2010) miR-145-mediated suppression of cell growth, invasion and metastasis. Am. J. Transl. Res., 2, 170-180.
19. Larsson,E. et al. (2009) Discovery of microvascular miRNAs using public gene expression data: miR-145 is expressed in pericytes and is a regulator of Fli1. Genome Med., 1, 108.
20. Sachdeva,M. et al. (2010) MicroRNA-145 suppresses cell invasion and metastasis by directly targeting mucin 1. Cancer Res., 70, 378-387.
21. Seoane,J. et al. (2002) Myc suppression of the p21(Cip1) Cdk inhibitor influences the outcome of the p53 response to DNA damage. Nature, 419, 729-734.
22. Wang,L. et al. (2009) Gene networks and microRNAs implicated in aggressive prostate cancer. Cancer Res., 69, 9490-9497.
23. Chen,X. et al. (2010) MicroRNA145 targets BNIP3 and suppresses prostate cancer progression. Cancer Res., 70, 2728-2738.
24. Lujambio,A. et al. (2007) CpG island hypermethylation of tumor suppressor microRNAs in human cancer. Cell Cycle, 6, 1455-1459.
25. Corney,D.C. et al. (2010) Frequent downregulation of miR-34 family in human ovarian cancers. Clin. Cancer Res., 16, 1119-1128.
26. Chandran,U.R. et al. (2005) Differences in gene expression in prostate cancer, normal appearing prostate tissue adjacent to cancer and prostate tissue from cancer free organ donors. BMC Cancer, 5, 45.
27. Mehrotra,J. et al. (2008) Quantitative, spatial resolution of the epigenetic field effect in prostate cancer. Prostate, 68, 152-160.
28. Yu,Y.P. et al. (2004) Gene expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancy. J. Clin. Oncol., 22, 2790-2799.
29. Weber,B. et al. (2007) Methylation of human microRNA genes in normal and neoplastic cells. Cell Cycle, 6, 1001-1005.
30. Lodygin,D. et al. (2008) Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer. Cell Cycle, 7, 2591-2600.
31. Toyota,M. et al. (2008) Epigenetic silencing of microRNA-34b/c and Bcell translocation gene 4 is associated with CpG island methylation in colorectal cancer. Cancer Res., 68, 4123-4132.
32. Soussi,T. et al. (2006) Locus-specific mutation databases: pitfalls and good practice based on the p53 experience. Nat. Rev. Cancer, 6, 83-90.
33. Dong,J.T. (2006) Prevalent mutations in prostate cancer. J. Cell. Biochem., 97, 433-447.
34. Hermeking,H. (2007) p53 enters the microRNA world. Cancer Cell, 12, 414-418.
35. Barlev,N.A. et al. (2010) The microRNA and p53 families join forces against cancer. Cell Death Differ., 17, 373-375.
36. Hanafusa,T. et al. (2005) Functional promoter upstream p53 regulatory sequence of IGFBP3 that is silenced by tumor specific methylation. BMC Cancer, 5, 9.
37. Haupt,Y. et al. (1997) Mdm2 promotes the rapid degradation of p53. Nature, 387, 296-299.
38. Kubbutat,M.H. et al. (1997) Regulation of p53 stability by Mdm2. Nature, 387, 299-303.